Concepedia

Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials

Mattía Galli, Stefano Benenati, Francesco Franchi, Fabiana Rollini, Davide Capodanno, Giuseppe Biondi‐Zoccai, Giovanni Maria Vescovo, Larisa H. Cavallari, Behnood Bikdeli, Jurriën M. ten Berg,

European Heart Journal · 2021 · 146 citations · 26 references

DOIFull text

Open access

Abstract

A guided selection of P2Y12-inhibiting therapy represents the strategy associated with the most favourable balance between safety and efficacy. These findings support a broader adoption of guided P2Y12 inhibiting therapy in patients with acute coronary syndrome.

References

26

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins, Doug Altman, Peter C Gøtzsche et al. · BMJ · 2011 · 32.9K citations · Full text

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

Systematic Reviews · 2015 · 25.2K citations · Full text

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Borja Ibáñez, Stefan James, Stefan Agewall et al. · European Heart Journal · 2017 · 9.5K citations · Full text

, , +19

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Lars Wallentin, Richard C. Becker, Andrzej Budaj et al. · New England Journal of Medicine · 2009 · 7K citations · Full text

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe et al. · New England Journal of Medicine · 2007 · 6.7K citations · Full text